Skip to content

CROI: Delaying HAART while treating opportunistic infections increases the risk of disease progression and death

CROI: Biomarker changes may help explain detrimental effects of treatment interruption

CROI: Nanoparticle technology creates a once-a-month HIV drug

CROI: Three children in US infected with HIV from pre-chewed food

CROI: Risk of second virological failure has declined since 1996, but risk of death remains stable

CROI: Herpes virus suppression with valaciclovir lowers viral load in HIV positive women: could work for gay men too

CROI: AIDS vaccine: additional infection risk restricted to uncircumcised men

CROI: People receiving TB treatment no more likely to die than others who start ARVs

CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients